Markets:

Overview

News

Currencies

International

Treasuries

PureTech Health plc - American Depositary Shares (NQ:PRTC)

18.53 -0.55 (-2.88%)

Streaming Delayed Price Updated: 1:44 PM EST, Jan 23, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about PureTech Health plc - American Depositary Shares

< Previous 1 2 3 4 5 6 7 8 9 Next >

PureTech Advances Wholly-Owned Candidate LYT-300 (Oral Allopregnanolone) into Clinical Study for Potential Treatment of Neurological and Neuropsychological Conditions

December 07, 2021

From PureTech Health plc

Via Business Wire

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

December 02, 2021

Gainers Biofrontera (NASDAQ:BFRI) shares ...

Via Benzinga

PureTech Founded Entity Gelesis Announces FDA-Cleared Weight Management Approach, Plenity®, Now Broadly Available and Leading Nutrition Authority Joy Bauer, MS, RDN, CDN, Joins as Chief Nutrition Officer

December 01, 2021

From PureTech Health plc

Via Business Wire

PureTech Founded Entity Gelesis Receives $30 Million Plenity® Order from Ro

November 18, 2021

From PureTech Health plc

Via Business Wire

PureTech Announces Publication of Phase 1 Results for LYT-100 in the Journal Clinical Pharmacology in Drug Development and Provides Timing Updates

November 16, 2021

From PureTech Health plc

Via Business Wire

PureTech Announces Participation in Two Upcoming Investor Conferences

November 15, 2021

From PureTech Health plc

Via Business Wire

PureTech Presents Clinical Trial Design Supporting Wholly Owned Immuno-Oncology Candidate LYT-200 at the Society for Immunotherapy of Cancer (SITC) 36th Annual Meeting

November 12, 2021

From PureTech Health plc

Via Business Wire

PureTech Receives Orphan Drug Designation for Wholly Owned Candidate LYT-200 for the Treatment of Pancreatic Cancer

November 11, 2021

From PureTech Health plc

Via Business Wire

PureTech Founded Entity Karuna Therapeutics and Zai Lab Announce Strategic Collaboration for Development, Manufacturing, and Commercialization of KarXT in Greater China

November 09, 2021

From PureTech Health plc

Via Business Wire

PureTech Announces Participation at the Jefferies London Healthcare Conference

November 09, 2021

From PureTech Health plc

Via Business Wire

PureTech Is Pleased to Note Publication in Nature’s Scientific Reports Featuring the Gelesis Foundational Biomimetic Platform for Treating Obesity and Conditions Related to Diet-Induced Gut Damage

November 01, 2021

From PureTech Health plc

Via Business Wire

PureTech Founded Entity Vedanta Biosciences Appoints Simona Levi as Chief Legal Officer and Corporate Secretary

October 14, 2021

From PureTech Health plc

Via Business Wire

PureTech Founded Entity Vedanta Announces Positive Topline Phase 2 Data for VE303 in High-Risk C. difficile Infection and Exercise of $23.8 Million Option by BARDA

October 05, 2021

From PureTech Health plc

Via Business Wire

PureTech Founded Entity Sonde Health Launches Vocal Biomarker Technology to Monitor Mental Health and Well-Being

October 05, 2021

From PureTech Health plc

Via Business Wire

PureTech Founded Entity Akili Announces Topline Results from Shionogi Phase 2 Study in Japan

September 29, 2021

From PureTech Health plc

Via Business Wire

PureTech Announces Publication of New Preclinical Research from Collaborators that Supports Mesenteric Lymphatic Dysfunction as a Potential Cause of and Therapeutic Target for Obesity and Insulin Resistance

September 20, 2021

From PureTech Health plc

Via Business Wire

PureTech to Present at Oppenheimer Fall Healthcare Life Sciences and MedTech Summit

September 14, 2021

From PureTech Health plc

Via Business Wire

PureTech Founded Entity Vor Biopharma Announces VOR33 Granted U.S. FDA Fast Track Designation for Acute Myeloid Leukemia

September 10, 2021

From PureTech Health plc

Via Business Wire

12 Health Care Stocks Moving In Monday's Intraday Session ↗

August 30, 2021

Gainers Valneva (NASDAQ:VALN) stock moved upwards by 29.61% to $49.9 during Monday's regular session. Valneva's stock is trading at a volume of 143.0K shares as of...

Via Benzinga

Earnings Scheduled For August 24, 2021 ↗

August 24, 2021

Companies Reporting Before The Bell • 36KR Holdings (NASDAQ:KRKR) is likely to report earnings for its second quarter. • Genetron Holdings (NASDAQ:GTH) is...

Via Benzinga

PureTech Health plc – Half-Year Report

August 24, 2021

From PureTech Health plc

Via Business Wire

PureTech Presents Phase 1 Data for LYT-100 at the European Respiratory Society International Congress 2021

August 23, 2021

From PureTech Health plc

Via Business Wire

PureTech Founded Entity Akili Enters Strategic Licensing Agreement with TALi, Extending Akili Portfolio and Industry Leadership in Prescription Digital Therapeutics for Cognitive Impairments

August 17, 2021

From PureTech Health plc

Via Business Wire

PureTech Announces the Appointment Julie Krop, M.D., as Chief Medical Officer

August 13, 2021

From PureTech Health plc

Via Business Wire

Imbrium Therapeutics To Develop PureTech's Non-Opioid Candidate For Chronic Bladder Condition ↗

August 11, 2021

Imbrium Therapeutics has exercised a license option to develop PureTech Health plc's (NASDAQ: PRTC) LYT-503/IMB-150 (formerly designated as ALV-107...

Via Benzinga

PureTech Announces That Imbrium Therapeutics Has Exercised License Option to LYT-503/IMB-150 for Interstitial Cystitis/Bladder Pain Syndrome

August 11, 2021

From PureTech Health plc

Via Business Wire

PureTech: Notice of Half-Yearly Results

August 03, 2021

From PureTech Health plc

Via Business Wire

The Week In SPAC News - Sunday, July 25 ↗

July 25, 2021

In SPAC news this week, BBQGuys, PropertyGuru, and Cvent announced merger deals, while Vice Media's plan to go public via a SPAC merger has reportedly stalled.

Via Talk Markets

PureTech Founded Entity Akili Releases New Gameplay Features in the First and Only FDA-Cleared Video Game Treatment for Children With ADHD

July 22, 2021

From PureTech Health plc

Via Business Wire

PureTech Founded Entity Vedanta Biosciences Completes $68 Million Series D Financing

July 21, 2021

From PureTech Health plc

Via Business Wire

< Previous 1 2 3 4 5 6 7 8 9 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.